Efficacy of Premedication Protocol Without Ranitidine for Taxane Regimen : A Multicenter Non-Randomized Historical Controlled Study
Phase 3
Completed
- Conditions
- Hypersensitivity reactions in patients who received taxane chemotherapy regimen between standard premedication protocol and modified premedication protocol without ranitidine.
- Registration Number
- TCTR20210322004
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 221
Inclusion Criteria
1. Cancer patients who received taxane chemotherapy regimen
Exclusion Criteria
1.History of severe Hypersensitivity reactions from taxane regimen
2.Severe hepatic impairment (bilirubin >5xULN or AST/ALT >10xULN)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hypersensitivity reactions every 3 week of six-cycle course of chemotherapy grading of Hypersensitivity reactions
- Secondary Outcome Measures
Name Time Method /A N/A N/A